Minerva Neurosciences, Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NERV Company Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
NERV Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NERV Smart Score
Score Breakdown
NERV Company Description
Show More
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NERV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NERV's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on NERV's company Twitter account
WallStreetBets
Number of mentions of NERV in WallStreetBets Daily Discussion
NERV News
Recent insights relating to NERV
CNBC Recommendations
Recent picks made for NERV stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NERV
Corporate Flights
Flights by private jets registered to NERV
Our Analysis